PubRank

María José Martí

Author PubWeight™ 16.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006 4.72
2 The MC1R melanoma risk variant p.R160W is associated with Parkinson disease. Ann Neurol 2015 2.71
3 G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. J Neurol Neurosurg Psychiatry 2007 1.24
4 Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 2005 1.07
5 Further extension of the H1 haplotype associated with progressive supranuclear palsy. Mov Disord 2002 0.98
6 Long lasting pure freezing of gait preceding progressive supranuclear palsy: a clinicopathological study. Mov Disord 2007 0.95
7 Intranigral infusion of interleukin-1beta activates astrocytes and protects from subsequent 6-hydroxydopamine neurotoxicity. J Neurochem 2003 0.84
8 Ziprasidone versus clozapine in the treatment of psychotic symptoms in Parkinson disease: a randomized open clinical trial. Clin Neuropharmacol 2012 0.80
9 Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study. J ECT 2012 0.79
10 Correlates of cerebrospinal fluid levels of oligomeric- and total-α-synuclein in premotor, motor and dementia stages of Parkinson's disease. J Neurol 2014 0.78
11 [Levodopa in the treatment of Parkinson's disease: myths and realties]. Rev Neurol 2012 0.78
12 G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies. BMJ Case Rep 2009 0.77
13 Eating-induced facial myoclonic dystonia probably due to a putaminal lesion. Mov Disord 2007 0.75